Cabozantinib | compare suppliers & send inquiries for free
MOQ: 0 kg
Shandong Octagon Chemicals Limited
MOQ: 1 g
Looking for Cabozantinib 849217-68-1?
What can you use it for? Cabozantinib was first approved in 2012 and is a non-specific tyrosine kinase inhibitor. It was initially approved in the US under the brand name Cometriq, which is indicated for the treatment of metastatic medullary thyroid cancer. In 2016, a capsule formulation (Cabometyx) was approved for the treatment of advanced renal cell carcinoma, and this same formulation gained additional approval in both the US and Canada in 2019 for the treatment of hepatocellular carcinoma in previously treated patients
Not sure if this is the exact product you're looking for? Contact the supplier by using the send inquiry button.
Cabozantinib manufacturers | traders | suppliers
We have 2 companies offering Cabozantinib from 2 different countries.
Get in contact with the supplier of your choice:
- MSN Labs. from India
- Shandong Octagon Chemicals Limited from China
Let the supplier know whether you are looking for a product with a specific monograph such as EP (Ph. Eur.), USP, JP, BP or another quality. Or, whether you are looking for hydrochloride (HCl), anhydricum, base, micronisatum or a specific purity.
You can use the filters to find high-quality suppliers. For example, you can select GMP, FDA or ISO certified suppliers. Visit our FAQ page or use the chat box in the corner to get more information about Pharmaoffer.